the value of glutathione-s-transferase gene polymorphisms (gstm1, gstt1) in various inflammatory phenotypes of bronchial asthma in children

Clicks: 287
ID: 244434
2014
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #15 of 94 articles by views in scientific electronic archives

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
The aim of research: to study the peculiarities of a heterogeneous airway inflammation in children with bronchial asthma (BA) under the deletion polymorphism of GSTM1 and GSTT1 genes. Materials and Methods. We have examined 102 school-aged children with BA, of whom in 46 patients (I clinical group) the eosinophilic type of bronchial inflammation was verified, in 33 patients (II clinical group) — the neutrophilic type, and in 23 children (ІІІ group) — paucigranulocytic nature of inflammatory changes in the bronchi. Results. In patients with bronchial asthma, the homozygous deletion of GSTT1 gene has been detected in every fifth child, independently of type of airway inflammation. In patients with eosinophilic subtype of inflammation of the bronchi, GSTM1 gene deletion was noted in 32.6 % of cases, with neutrophilic one — in 51.1 % and with paucigranulocytic — 21.7 % of cases. In children with T1delM1+ genotype, severe BA in I group was detected in 37.5 % of cases, in the II — in 50.0 %, and in III group — in 100 % of cases (PIII : I,II < 0.05). Conclusions. Thus, children with different inflammatory phenotypes of asthma have certain characteristics of the disease course in the presence of GSTM1 and GSTT1 genes deletion polymorphism, which should be considered when choosing a treatment strategy in these patients.
Reference Key
koloskova2014zdorovethe Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;O.K. Koloskova;L.O. Bezrukov;T.M. Bilous;O.G. Grygola;Ye.P. Ortemenka
Journal scientific electronic archives
Year 2014
DOI
10.22141/2224-0551.6.57.2014.75719
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.